CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-18 | Hefti Brenda SVP and General Counsel | Sale 10b5-1 | −6,625 | $50.21 | $333K | 106,762 |
| 2026-05-15 | Hefti Brenda SVP and General Counsel | Shares withheld for taxes 10b5-1 | −6,411 | $51.10 | $328K | 113,387 |
| 2026-02-26 | Hefti Brenda SVP and General Counsel | Grant or award | +23,119 | 119,631 | ||
| 2026-02-18 | Hefti Brenda SVP and General Counsel | Sale 10b5-1 | −18,669 | $44.01 | $822K | 96,512 |
| 2026-02-15 | Hefti Brenda SVP and General Counsel | Shares withheld for taxes 10b5-1 | −5,430 | $43.92 | $238K | 115,181 |
| 2025-12-03 | Hefti Brenda SVP and General Counsel | Grant or award | +30,170 | 120,611 |
Page 1 of 1 · 6 trades